4.6 Letter

Ubiquilin immunoreactivity in cytoplasmic and nuclear inclusions in synucleinopathies, polyglutamine diseases and intranuclear inclusion body disease

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion

Johannes Brettschneider et al.

ACTA NEUROPATHOLOGICA (2012)

Article Clinical Neurology

FUS immunoreactivity of neuronal and glial intranuclear inclusions in intranuclear inclusion body disease

F. Mori et al.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2012)

Article Multidisciplinary Sciences

Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia

Han-Xiang Deng et al.

NATURE (2011)

Article Multidisciplinary Sciences

Mutations of optineurin in amyotrophic lateral sclerosis

Hirofumi Maruyama et al.

NATURE (2010)

Article Multidisciplinary Sciences

Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis

T. J. Kwiatkowski et al.

SCIENCE (2009)

Article Biochemistry & Molecular Biology

Identification of ubiquitin-interacting proteins in purified polyglutamine aggregates

H Doi et al.

FEBS LETTERS (2004)